Deliver Your News to the World Reports 250% Increase In Actos Complaints

Actos lawsuits cause for concern as diabetes patients seek Avandia alternatives


SANTA CRUZ, Calif., April 23,, 2012 – On March 27, 2012 the American Diabetes Association Alert Day® called on Americans to assess their risk for developing type 2 diabetes. According to the Centers for Disease Control and Prevention, 25.8 million Americans are currently affected by the disease, and if statistics released by are any indication, Actos will be on the minds of many.

Actos (pioglitazone), a type 2 diabetes drug manufactured by Takeda Pharmaceuticals North America, Inc. and once considered a safer alternative to Avandia, has become the target of lawsuits concerning Actos bladder cancer, as well as Actos heart failure.

In the aftermath of the Food and Drug Administration’s (FDA) mandate to limit availability of Avandia to patients enrolled in the REMS Avandia-Rosiglitazone Medicines Access Program, has seen a marked increase in Actos side effects complaints seeking legal help. Specifically, complaints in 2011for Actos side effects involving Actos bladder cancer and Actos heart failure increased 250 percent over 2010.

Diabetes currently affects 8.3 percent of the U.S. population and that number is forecast to grow as the largest segment of the population continues to age. With tightened FDA restrictions on the availability of Avandia, Actos was increasingly seen as the preferred type 2 diabetes medication within the same diabetes drug class (thiazolidinediones).

Attorney J. Benton Stewart II of Stewart Law, PLLC, notes that, “At the time, it was believed that Actos was not as harmful a drug as Avandia, but over time that has not been proven to be true,” he says. “The FDA has linked Actos to bladder cancer, which is now a warning on the Actos label.”

Given the chain of events regarding these diabetes medications, including the outcome of the Avandia FDA investigation, the subsequent focus on Actos as a potential replacement for Avandia and the addition of an Actos bladder cancer warning by the FDA in June 2011, diabetes patients have been left with many questions for which they turn to for the latest legal news and information regarding Actos lawsuits.

"Patients who took Avandia before Actos or who were turned down in the Avandia litigation because they also took Actos may be eligible to file a claim against the makers of Actos,” Stewart suggests. provides comprehensive legal news and critical information for those affected by once-in-a-lifetime situations involving medical device lawsuits,personal injury, defective products, California Overtime and labor issues or a host of others. Readers seeking legal help can request it by completing a form which is distributed to attorneys specializing in these cases. Trial attorneys utilize the site to keep abreast of hot legal issues and settlements as well as connect with potential clients. Web:

About Online Legal Media

Online Legal Media owns and operates websites providing information for the general public and the legal community., founded in 2001, is an online legal news publication with over 2.1 million visitors annually and hundreds of thousands of requests for attorney help from its readership. serves as a portal for trial attorneys to network and to market their firms to other attorneys and legal professionals. offers up-to-date resources and news for those suffering from asbestos exposure and mesothelioma. Online Legal Media is based in Santa Cruz, California.

Follow Online Legal Media on Twitter @OnlineLegalNews and on Facebook at .


 Actos bladder cancer
 medical device lawsuit
 personal injury

This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.